
ABSTRACTTuberculosis subunit vaccines codelivered with interleukin-12 (IL-12)-encapsulated microspheres (IL-12EM) are designed for a sustained release of IL-12 and could induce strong Th1 immune responses specific to Ag85A and ESAT-6. The adjuvant combination of IL-12EM plus AS01B was a more efficient way to induce a sustained Th1 immunity and protection againstMycobacterium tuberculosis.
ANTIGEN, PLGA MICROSPHERES, Tuberculosis/prevention & control*, 610, Bacterial/blood*, Capsules, CONTROLLED-RELEASE, Inbred C57BL, Antibodies, Immunologic*, Mice, Adjuvants, Immunologic, Bacterial Proteins, Mycobacterium tuberculosis/pathogenicity, Bacterial/immunology, ANTITUMOR IMMUNITY, Tuberculosis Vaccines/immunology*, Animals, Tuberculosis, Th1 Cells/immunology, Adjuvants, Antigens, Tuberculosis Vaccines, Tuberculosis/immunology, Antigens, Bacterial, BIODEGRADABLE MICROSPHERES, INTERFERON-GAMMA, Vaccination, MEMORY CELLS, IN-VITRO, Mycobacterium tuberculosis, Tuberculosis Vaccines/administration & dosage, Th1 Cells, Microspheres*, Antibodies, Bacterial, Interleukin-12, Microspheres, Acyltransferases/immunology, Mice, Inbred C57BL, Delayed-Action Preparations, T-CELLS, Interleukin-12/immunology*, Mycobacterium tuberculosis/immunology, MYCOBACTERIUM-TUBERCULOSIS, Acyltransferases
ANTIGEN, PLGA MICROSPHERES, Tuberculosis/prevention & control*, 610, Bacterial/blood*, Capsules, CONTROLLED-RELEASE, Inbred C57BL, Antibodies, Immunologic*, Mice, Adjuvants, Immunologic, Bacterial Proteins, Mycobacterium tuberculosis/pathogenicity, Bacterial/immunology, ANTITUMOR IMMUNITY, Tuberculosis Vaccines/immunology*, Animals, Tuberculosis, Th1 Cells/immunology, Adjuvants, Antigens, Tuberculosis Vaccines, Tuberculosis/immunology, Antigens, Bacterial, BIODEGRADABLE MICROSPHERES, INTERFERON-GAMMA, Vaccination, MEMORY CELLS, IN-VITRO, Mycobacterium tuberculosis, Tuberculosis Vaccines/administration & dosage, Th1 Cells, Microspheres*, Antibodies, Bacterial, Interleukin-12, Microspheres, Acyltransferases/immunology, Mice, Inbred C57BL, Delayed-Action Preparations, T-CELLS, Interleukin-12/immunology*, Mycobacterium tuberculosis/immunology, MYCOBACTERIUM-TUBERCULOSIS, Acyltransferases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 32 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
